Grupo Financiero Banorte, S.A.B. De C.V. (GBOOY: OTCQX

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Grupo Financiero Banorte, S.A.B. De C.V. (GBOOY: OTCQX International Premier) | GRUPO FINANCIERO BANORTE ANNOUNCES INTENTION TO CONDUCT AN INITIAL PUBLIC OFFERING

Grupo Financiero Banorte, S.A.B. de C.V. (?GFNORTE?) (BMV: GFNORTEO) informs the investment public that it intends to offer its common shares in a public primary offering in Mexico and a private offering in certain foreign markets, subject to market conditions, the corresponding corporate and regulatory authorizations, and other conditions.

 

In this regard, GFNORTE has filed an application with the National Banking and Securities Commission ( Comisi?n Nacional Bancaria y de Valores ) to update the registration of its common shares in the National Registry of Securities ( Registro Nacional de Valores ) and to be allowed to publicly offer such common shares in Mexico.  

 

GFNORTE plans to conduct the offering as soon as the corresponding authorizations are obtained and market conditions permit, for an amount of up to U.S.$3.0 billion, which will consist of a public primary offering in Mexico through the Mexican Stock Exchange ( Bolsa Mexicana de Valores, S.A.B. de C.V. ), and an international offering in the United States of America pursuant to Rule 144A of the U.S. Securities Act of 1933, and outside of the United States of America in accordance with Regulation S of the Securities Act and the corresponding legislation in the countries where the offering takes place.       

 

This press release is solely for informational purposes, pursuant to the terms of article 50, section III, paragraph i) of the General Provisions Applicable to Securities Issuers and other Stock Market Participants ( Disposiciones de Car?cter General Aplicables a las Emisoras de Valores y a Otros Participantes del Mercado de Valores ), and does not constitute an offering of subscription or sale, nor an application to subscribe or sell shares of GFNORTE in Mexico, the United States of America or any other jurisdiction.

 

The common shares will not be registered under the Securities Act, and may not be offered or sold in the United States without registration under the Act or pursuant to an applicable exemption from such registration. Common shares may only be offered in the United States to qualified institutional buyers as defined under Rule 144A, and outside of the United States pursuant to the provisions of Regulation S of the Securities Act.

 

GFNORTE reiterates to the investment public that it will continue adopting the best international corporate practices regarding Corporate Governance and information disclosure.   The Financial Group will maintain its strategic and expansion plans to consolidate a leading institution in Mexico; in this sense, we will timely inform the investment community regarding the strategy execution and evolution of our operations.   The Investor Relations Department is available for any inquiry or comment regarding this material event at: i nvestor@banorte.com or in the number (55) 52.68.16.80.

About Grupo Financiero Banorte

Banorte was founded in 1899 in the city of Monterrey, where it first started operations as a small regional player. In 1992, in the banking privatization process, Banorte was acquired by a group of entrepreneurs leaded by Roberto Gonzalez Barrera. Through a series of key acquisitions after the Mexican financial crisis of the mid 1990?s, like Bancen and Banpa?s in 1997 and Bancrecer in 2002, Banorte was able to consolidate a nationwide presence in Mexico. It now operates as a financial group known as Grupo Financiero Banorte, offering universal banking products and services in the Mexican financial system. Banorte is currently the third largest banking institution in Mexico measured by size of loans and deposits. It is the largest provider of State & Municipal government financing, the second in mortgage financing and the third largest provider of commercial loans. As well as increasing its market shares, Banorte has consolidated its position as one of Mexico's most profitable banks and is recognized for its strong fundamentals by showing sound asset quality, as well as high liquidity and capitalization levels.

With more than 2 6 million clients and a footprint of more than 1,300 branches and approximately 6,700 ATMs nationwide, GFNORTE?s main business line is retail banking, and it also provides a wide array of products and services through its broker dealer, insurance company , retirements savings funds (Afore), mutual fund operator , leasing & factoring compan ies and warehousing. GFNORTE manages more than US 1 48 billion in assets and Banorte is the only retail bank, among the six largest institutions of the country, that is controlled by Mexican shareholders. Its decisions are taken locally without the influence of international headquarters, which has proven to be an advantage given the recent weakness of many global institutions. In 2006, Banorte entered into the U.S. Hispanic market through the purchase of Inter National Bank ( ? INB ? ), a Texas-based bank, and two remittance companies in 2007: Uniteller in New Jersey and Motran in California. In 2011, Ixe Grupo Financiero merged with GFNORTE. Its strategic partnerships include the International Finance Corporation (?IFC?) at its banking subsidiary, the Mexican Social Security Institute (?IMSS?) at the retirement savings fund management business, and the Italian insurance company Generali at the insurance and annuities business. In January 2013, GFNORTE finalized the acquisition of Afore Bancomer through Afore XXI Banorte, becoming the most relevant transaction to date in the retirement savings fund system and creating the most significant Afore in Mexico. GFNORTE?s shares trade in the Mexican Stock Exchange (?BMV?) with the ticker ?GFNORTEO?, in the Madrid Stock Exchange under the symbol ?XNOR? and in the US ADR OTC market under ?GBOOY?. For further information, visit www.banorte.com .

 

Forward-Looking Information

 

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.   Words such as ?believe,? ?anticipate,? ?should,? ?estimate,? ?seek,? ?expect,? ?could,? ?plan,? ?will,? and similar expressions are intended to identify forward?looking statements but are not the exclusive means of identifying such statements.   By their very nature, forward?looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that the predictions, forecasts, projections and other forward?looking statements will not be achieved or will differ from actual results.   You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results to differ materially from those anticipated in the forward-looking statements.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 81

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Pennsylvania Rebate Rules Matter Before Year-End Filing

Updated Category News Views 70

A missed rebate form can sting harder than most people expect, especially when a household has already spent the year watching property taxes, rent, groceries, and every other stubborn bill chew through fixed income. Pennsylvania’s Property Tax/Rent Rebate Program is not glamorous, and it is certainly not an investing story. It is, however, the kind of direct household...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 66

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 139

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Sinopec's Green Fuel Push Meets a Hard Reality Check

Updated Category News Views 150

A refinery giant talking about green jet fuel at a climate summit is exactly the sort of thing that makes old energy hands squint first—and then check the asset list. Sinopec did bring more than lofty language to its Nov. 16 COP31 side event in Antalya: it brought long-range energy forecasts, named fuel-production routes, hydrogen infrastructure and operating projects....

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 160

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading

Top 5 Most Recently Viewed Articles

Japan's Economic Outlook Dims as Export Weakness Persists

Updated Category News Views 189

Japan's Revised Economic Growth Forecast Recently, Japan's government announced a downward revision of its GDP growth forecast for the current fiscal year. This adjustment is significant as it reflects the ongoing struggles within the economy, particularly in light of weaker export performance that is hindering a fragile recovery. Details on the Growth Projection The...

Continue Reading
The Importance of Employee Recognition in the Workplace

Updated Category News Views 254

The Importance of Employee Recognition in the Workplace Gratitude is a key theme during Thanksgiving, but in the workplace, recognition for employee contributions plays an equally significant role throughout the year. As companies strive to enhance their workplace culture, the value of recognizing employees cannot be overstated. Understanding Employer Perspectives A...

Continue Reading
Class Action Alert for Shareholders of Orthofix Medical

Updated Category News Views 196

Class Action Lawsuit Overview In the current landscape of securities litigation, investors in Orthofix Medical, Inc. have a critical opportunity to engage with a class action lawsuit that addresses significant issues of corporate governance and transparency. This legal action has arisen following severe corporate management changes that have caused share price...

Continue Reading
Understanding Recent Trends in Lowe's Short Interest

Updated Category News Views 107

Understanding Lowe's Companies' Short Interest Lowe's Companies (NYSE: LOW) has seen its short percent of float decrease by 12.78% since the last report. Currently, there are approximately 6.55 million shares sold short, which constitutes 1.16% of all shares available for trading. Given the current trading volume, it would take traders about 2.91 days to cover their short...

Continue Reading
YD Bio Limited and EG Biomed Enhance Clinical Testing with CAP Accreditation

Updated Category News Views 151

Transformative Advancements in Clinical Testing by YD Bio Limited YD Bio Limited, a pioneering biotechnology company known for its advancements in DNA methylation-based cancer detection, recently celebrated a significant milestone through its collaboration with EG Biomed US Inc. This partnership has propelled forward the capabilities of clinical testing, particularly in...

Continue Reading